Next-Generation Sequencing and Emerging Technologies*
Seminars in Thrombosis and Hemostasis · 01.10.2024 · 50 (07) · 1026-1038
DOI: 10.1055/s-0044-1786397 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Thrombosis and Hemostasis, erschienen am 01.10.2024. Verfasst von Kishore R Kumar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Translational Genomics Group, Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 91 Literaturangaben.
Abstract (Originalsprache)
Genetic sequencing technologies are evolving at a rapid pace with major implications for research and clinical practice. In this review, the authors provide an updated overview of next-generation sequencing (NGS) and emerging methodologies. NGS has tremendously improved sequencing output while being more time and cost-efficient in comparison to Sanger sequencing. The authors describe short-read sequencing approaches, such as sequencing by synthesis, ion semiconductor sequencing, and nanoball sequencing. Third-generation long-read sequencing now promises to overcome many of the limitations of short-read sequencing, such as the ability to reliably resolve repeat sequences and large genomic rearrangements. By combining complementary methods with massively parallel DNA sequencing, a greater insight into the biological context of disease mechanisms is now possible. Emerging methodologies, such as advances in nanopore technology, in situ nucleic acid sequencing, and microscopy-based sequencing, will continue the rapid evolution of this area. These new technologies hold many potential applications for hematological disorders, with the promise of precision and personalized medical care in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Translational Genomics Group, Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
- Department of Neurogenetics, Kolling Institute, University of Sydney and Royal North Shore Hospital, St Leonards, New South Wales, Australia.
- Molecular Medicine Laboratory, Concord Hospital, Sydney, Australia.
- Computational Biology Group, Children's Cancer Institute, University of New South Wales, Randwick, New South Wales, Australia.
ORCID-Profile: Kishore R Kumar, Mark J Cowley, Ryan L Davis
Zitieren
APA
Kumar, K. R., Cowley, M. J., & Davis, R. L. (2024). Next-Generation Sequencing and Emerging Technologies*. Seminars in Thrombosis and Hemostasis, 50(07), 1026-1038. https://doi.org/10.1055/s-0044-1786397
Vancouver
Kumar KR, Cowley MJ, Davis RL. Next-Generation Sequencing and Emerging Technologies*. Seminars in Thrombosis and Hemostasis. 2024;50(07):1026-1038. doi:10.1055/s-0044-1786397
BibTeX
@article{Kumar2024,
author = {Kumar, Kishore R and Cowley, Mark J and Davis, Ryan L},
title = {Next-Generation Sequencing and Emerging Technologies*},
journal = {Seminars in Thrombosis and Hemostasis},
year = {2024},
volume = {50},
number = {07},
pages = {1026--1038},
doi = {10.1055/s-0044-1786397}
}
EUVIMED